Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval

Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval

Source: 
EP Vantage
snippet: 

Vertex is due the first pivotal data on its cystic fibrosis triplets, while Global Blood Therapeutics will soon find out whether it can take a shortcut on voxelotor’s path to market.